{
    "Trade/Device Name(s)": [
        "BD ProbeTec\u2122 Chlamydia trachomatis (CT) Qx Amplified DNA Assay"
    ],
    "Submitter Information": "BD Diagnostic Systems",
    "510(k) Number": "K090824",
    "Predicate Device Reference 510(k) Number(s)": [
        "K081824",
        "K053446"
    ],
    "Regulatory Class": "Class I",
    "Product Code(s)": [
        "MKZ"
    ],
    "Summary Letter Date": "March 25, 2009",
    "Summary Letter Received Date": "March 26, 2009",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 866.3120"
    ],
    "Regulation Name(s)": [
        "Chlamydia serological reagents"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Chlamydia trachomatis DNA"
    ],
    "Specimen Type(s)": [
        "Female endocervical swab",
        "Male urethral swab",
        "Patient-collected vaginal swab",
        "Male urine",
        "Female urine",
        "Gynecological specimens collected in PreservCyt Solution"
    ],
    "Specimen Container(s)": [
        "Extraction Tube",
        "PreservCyt Solution container",
        "LBC Specimen Dilution Tube"
    ],
    "Instrument(s)/Platform(s)": [
        "BD Viper System"
    ],
    "Method(s)/Technology(ies)": [
        "Strand Displacement Amplification (SDA)",
        "Fluorescent detection",
        "DNA probe",
        "Nucleic acid amplification"
    ],
    "Methodologies": [
        "DNA extraction",
        "Automated amplification",
        "Qualitative detection"
    ],
    "Submission Type(s)": [
        "Assay",
        "Reagent",
        "System"
    ],
    "Document Summary": "FDA 510(k) summary for BD ProbeTec Chlamydia trachomatis (CT) Qx Amplified DNA Assay using SDA and BD Viper System for detection of Chlamydia trachomatis DNA in swab, urine, and gynecological specimens",
    "Indications for Use Summary": "Direct, qualitative detection of Chlamydia trachomatis DNA in clinician-collected female endocervical and male urethral swab specimens, patient-collected vaginal swab specimens, male and female urine specimens, and gynecological specimens collected in PreservCyt Solution, for diagnosis of chlamydial urogenital disease in symptomatic and asymptomatic individuals",
    "fda_folder": "Microbiology"
}